ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record14 judgments2 judges (our rules as one)0 record changes seen
Model not recordedOur rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03725059Study of Pembrolizumab(MK-3475) Versus Placebo inCombination WithNeoadjuvant Chemotherapy &Adjuvant Endocrine Therapyin the Treatment ofEarly-Stage EstrogenMerck Sharp & Dohme LLCPhase 3 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSPembrolizumabEntry “Pembrolizumab (K)”, read by ou…›Nov 1 · A model not recorded · TestedNov 18 · Our role rule · TestedTestedPaclitaxelEntry “Paclitaxel (X)”, read by our n…›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundDoxorubicinEntry “Doxorubicin (A)”, read by our …›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundEpirubicinEntry “Epirubicin (E)”, read by our n…›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundCyclophosphamideEntry “Cyclophosphamide (C)”, read by…›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundINT010015Entry “Endocrine therapy”, read by ou…›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · TestedBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Pembrolizumab (K)”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 1PaclitaxelA model not recordedBackgroundCurrent
Nov 1DoxorubicinA model not recordedBackgroundCurrent
Nov 1EpirubicinA model not recordedBackgroundCurrent
Nov 1CyclophosphamideA model not recordedBackgroundCurrent
Nov 1INT010015A model not recordedBackgroundCurrent
Nov 14Breast NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 18PembrolizumabOur role ruleTestedAgrees
Nov 18PaclitaxelOur role ruleBackgroundAgrees
Nov 18DoxorubicinOur role ruleBackgroundAgrees
Nov 18EpirubicinOur role ruleBackgroundAgrees
Nov 18CyclophosphamideOur role ruleBackgroundAgrees
Nov 18INT010015Our role ruleTestedOverridden
As of nowBreast NeoplasmsOur main-condition rule (R9)Main conditionCurrent